Oxford BioDynamics Plc (AIM:OBD)
London · Delayed Price · Currency is GBP · Price in GBX 0.4500
+0.0250 (5.88%)
Aug 15, 2025, 4:35 PM GMT+1
Oxford BioDynamics Market Cap
Oxford BioDynamics has a market cap or net worth of 8.81 million as of August 15, 2025. Its market cap has decreased by -57.97% in one year.
Market Cap
8.81M
Enterprise Value
9.69M
Revenue
896.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.45
Market Cap Chart
Since December 6, 2016, Oxford BioDynamics's market cap has decreased from 136.90M to 8.81M, a decrease of -93.57%. That is a compound annual growth rate of -27.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 8.81M | 83.91% |
| Dec 31, 2024 | 4.79M | -91.54% |
| Dec 29, 2023 | 56.64M | 125.13% |
| Dec 30, 2022 | 25.16M | -34.45% |
| Dec 31, 2021 | 38.38M | -50.04% |
| Dec 31, 2020 | 76.82M | -29.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.66B |
| GSK plc | 57.45B |
| Haleon | 32.11B |
| Smith & Nephew | 11.74B |
| ConvaTec Group | 4.66B |
| Hikma Pharmaceuticals | 3.97B |
| Oxford Nanopore Technologies | 2.04B |
| HUTCHMED (China) | 2.01B |